Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

NBY - NovaBay Pharmaceuticals, Inc. Latest News | Finranks

Home

NBY

N

NovaBay Pharmaceuticals, Inc. (NBY)

ASE – Real Time Price. Currency in USD

1.50

-0.03 (-1.96%)

At close: Mar 27, 2026, 4:00 PM EDT

1.40

-0.10 (-6.67%)

After-hours: Mar 27, 2026, 7:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19%

NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19%

NovaBay Pharmaceuticals, Inc. (NYSE: NBY) announced Monday its corporate name change to Stablecoin Development Corporation, signaling a full shift toward a cryptocurrency-focused strategy.

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired 2.06 billion SKY tokens

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE American's continued listing standards.

Videos

No Data

There is no data to display

Press releases

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired 2.06 billion SKY tokens

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE American's continued listing standards.